  | Gordon, D. M., Beckers, P., CASTERMANS, E., Neggers, S. J., ROSTOMYAN, L., Bours, V., Pétrossians, P., Dideberg, V., Beckers, A., & Daly, A. (01 December 2021). Dutch Founder SDHB Exon 3 Deletion in Patients with Pheochromocytoma-Paraganglioma in South Africa. Endocrine Connections, 11 (1). doi:10.1530/EC-21-0560  Peer Reviewed verified by ORBi |
  | PETIGNOT, S., Daly, A., CASTERMANS, E., Korpershoek, E., Scagnol, I., BECKERS, P., Dideberg, V., Rohmer, V., Bours, V., & Beckers, A. (2020). Pancreatic neuroendocrine neoplasm associated with a familial MAX deletion. Hormone and Metabolic Research. doi:10.1055/a-1186-0790 Peer Reviewed verified by ORBi |
 | Daly, A., Cano, D. A., Venegas, E., PETROSSIANS, P., Dios, E., CASTERMANS, E., Flores-Martinez, A., Bours, V., Beckers, A., & Soto, A. (2019). AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. Endocrine Connections. doi:10.1530/EC-19-0027 Peer Reviewed verified by ORBi |
 | Parotte, M.-C., CASTERMANS, E., Bours, V., Beckers, A., & VALDES SOCIN, H. G. (September 2018). Hypercalcémie familiale bénigne révélée par des crises de colique néphrétique : description d'une nouvelle mutation du calcium sensing receptor (CasR) [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France. |
 | Daly, A.* , CASTERMANS, E.* , Oudijk, L., Guitelman, M. A., BECKERS, P., NECHIFOR, I., Neggers, S. J. C. M. M., SACRE, N., Van der Lely, A. J., Bours, V., de Herder, W. W., & Beckers, A. (13 March 2018). Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions. Endocrine-Related Cancer, 25 (5), 37–42. doi:10.1530/ERC-18-0065 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Descamps, O. S., Van Caenegem, O., Hermans, M., Balligand, J.-L., Beauloye, C., Bondue, A., Carlier, S., CASTERMANS, E., Chenot, F., Claeys, M., De Block, C., de Leener, A., De Meester, A., Demeure, F., De Raedt, H., Desmet, W., Elegeert, I., Guillaume, M., Hoffer, E., ... Belgian Atherosclerosis Society/Belgian Lipid Club (BAS/BLC), T. B. S. O. C. B. S. C. A. T. R. B. S. O. L. M. R. (2018). A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy). Atherosclerosis, 277, 369-376. doi:10.1016/j.atherosclerosis.2018.05.037 Peer Reviewed verified by ORBi |
 | Rostomyan, L., Daly, A., Pellegata, N., NECHIFOR, I., BETEA, D., CASTERMANS, E., Christ., E., & BECKERS, A. (2017). Long-term management of resistant acromegaly with pasireotide LAR in 2 cases with a familial AIP Mutation. In Acta Clinica Belgica. |
 | Rostomyan, L., Daly, A., Yuan, B., Fina, F., CABERG, J.-H., Trivellin, G., de Herder, W., Naves, L., Metzger, D., Cuny, T., Rabl, W., Shah, N., Jaffrain-Rea, M., Zatelli, M., Faucz, F., CASTERMANS, E., Nanni-Metellus, I., Lodish, M., Muhammad, A., ... Beckers, A. (2017). Somatic mosaicism is implicated in the etiology of XLAG syndrome. In Abstract book : Symposium "Perspectives in Endocrinology". |
 | Rostomyan, L., Daly, A., Yuan, B., Fina, F., CABERG, J.-H., Trivellin, G., de Herder, W., Naves, L. A., Metzger, D., Cuny, T., Rabl, W., Shah, N., Jaffrain-Rea, M., Zatelli, M., Faucz, F., CASTERMANS, E., Nanni-Metellus, I., Lodish, M., Muhammad, A., ... Beckers, A. (2016). Somatic mosaicism is implicated in the etiology of XLAG syndrome. In 26nd meeting of the Belgian Endocrine Society - Abstract book. |
 | Mangupli, R.* , Rostomyan, L.* , CASTERMANS, E., CABERG, J.-H., Camperos, P., Krivoy, J., Cuauro, E., BOURS, V., Daly, A., & BECKERS, A. (2016). Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening. Pituitary. doi:10.1007/s11102-016-0732-3 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Rostomyan, L., Mangupli, R., CASTERMANS, E., CABERG, J.-H., Camperos, P., Krivoy, J., Cuaruo, E., Bours, V., Daly, A., & BECKERS, A. (May 2016). Combined treatment with octreotide LAR and pegvisomant in patients with gigantism – acromegaly: clinical evaluation and genetic screening [Poster presentation]. European Congress of Endocrinology, Munich, Germany. doi:10.1530/endoabs.41.EP889 |
 | Daly, A., Yuan, B., Fina, F., CABERG, J.-H., Trivellin, G., Rostomyan, L., de Herder, W. W., Naves, L. A., Metzger, D., Cuny, T., Rabl, W., Shah, N. S., Jaffrain-Rea, M.-L., Zatelli, M. C., Faucz, F. R., CASTERMANS, E., Nanni-Metellus, I., Lodish, M., Muhammad, A., ... BECKERS, A. (02 March 2016). Somatic mosaicism underlies X-linked acrogigantism (XLAG) syndrome in sporadic male subjects. Endocrine-Related Cancer, 23 (4), 221-233. doi:10.1530/ERC-16-0082 Peer Reviewed verified by ORBi |
 | Castinetti, F.* , Daly, A.* , Stratakis, C., CABERG, J.-H., CASTERMANS, E., Trivellin, G., Rostomyan, L., Saveanu, A., Jullien, N., Reynaud, R., Barlier, A., Bours, V., Brue, T., & Beckers, A. (2016). GPR101 mutations are not a frequent cause of congenital isolated growth hormone deficiency. Hormone and Metabolic Research, 1-5. doi:10.1055/s-0042-100733 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Potorac, I., BETEA, D., MALAISE, O., Daniel, S., CASTERMANS, E., Bours, V., Daly, A., & Beckers, A. (2016). Une forme compliquée d'hypercalcémie hypocalciurique familiale. In Abstract book - Symposium "Perspectives in Endocrinology". |
 | Rostomyan, L., Lysy, P., Desfilles, C., Trivellin, G., CABERG, J.-H., Mohamed, A., Raverot, V., Mantovani, G., Naves, L., Cheetham, T., Shah, N. S., Metzger, D., Zatelli, M., Strebkova, N., Mazerkina, N., Lodish, M., Marbaix, E., Maiter, D., Brunelle, C., ... Beckers, A. (2016). The genetic causes of pituitary gigantism. In Abstract book - Symposium "Perspectives in Endocrinology". |
 | Daly, A., Lysy, P., Defilles, C., Rostomyan, L., Mohamed, A., CABERG, J.-H., Raverot, V., CASTERMANS, E., Marbaix, E., Maiter, D., Brunelle, C., Trivellin, G., Stratakis, C. A., BOURS, V., Raftopoulos, C., Beauloye, V., Barlier, A., & BECKERS, A. (2016). Growth hormone releasing hormone excess and blockade in X-LAG syndrome. Endocrine-Related Cancer. doi:10.1530/ERC-15-0478 Peer Reviewed verified by ORBi |
| CASTERMANS, E., Auriemma, R., Rostomyan, L., SACRE, N., CABERG, J.-H., Bours, V., Daly, A., & Beckers, A. (2015). Etude moléculaire du gène AIP sur plus de 1400 individus atteints d'adénome hypophysaire. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie. |
| Potorac, I., BETEA, D., PETROSSIANS, P., CASTERMANS, E., HAMOIR, E., Labasse, J., Bours, V., Daly, A., & Beckers, A. (2015). Hyperparathyroïdie primaire familiale isolée - corrélation génotype - phénotype des mutations MEN 1? In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie. |
| Potorac, I., BETEA, D., MALAISE, O., Daniel, S., CASTERMANS, E., Bours, V., Daly, A., & Beckers, A. (2015). Une forme compliquée d'hypercalcémie hypocalciurique familiale. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie. |
| Rostomyan, L., Daly, A., PETROSSIANS, P., Trivellin, G., Shah, N., Mantovani, G., Neggers, S., CASTERMANS, E., CABERG, J.-H., Chanson, P., Zacharieva, S., Naves, L., & Beckers, A. (2015). The genetic causes of pituitary gigantism. In Endocrine Abstracts. |
| Daly, A., Lodish, M., Trivellin, G., Rostomyan, L., Faucz, F., Yuan, B., Naves, L. A., Choong, C., Lysy, P., Shah, N. S., Verrua, E., CABERG, J.-H., CASTERMANS, E., Zatelli, C., Schernthaner-Reiter, M., Villa, C., Metzger, D., Strebkova, N., Mazerkina, N., ... Beckers, A. (2015). Disease characteristics of patients with X-linked acrogigantism (X-LAG) syndrome. In Abstract book - ENDO 2015. |
 | Stratakis, C., Trivellin, G., Rostomyan, L., Lodish, M., Faucz, F., Naves, L. A., Choong, C., Lysy, P., Shah, N. S., Verrua, E., CABERG, J.-H., CASTERMANS, E., JAMAR, M., Zatelli, M., Schernthaner-Reiter, M., Villa, C., Metzger, D., Strebkova, N., Mazerkina, N., ... Beckers, A. (2015). X-Linked acro-gigantism (X-LAG) syndrome : a new form of infant-onset pituitary gigantism. In Abstract book - 14th International Pituitary Congress. |
| Trivellin, G., Daly, A., Faucz, F., Yuan, B., Rostomyan, L., Larco, D., Schernthaner-Reiter, M., Szarek, E., Leal, L., CABERG, J.-H., CASTERMANS, E., Villa, C., Dimopoulos, A., Chittiboina, P., Xekouki, P., Shah, N. S., Metzger, D., Lysy, P., Ferrante, E., ... Stratakis, C. (2015). X-Linked acro-gigantism (X-LAG) due to microduplications of chromosome Xq26 : A new disorder and implications for acromegaly. In Abstract book - ENDO 2015. |
 | Thevenon, J., Bourredjem, A., Faivre, L., Bauters, C., Calender, A., Lebras, M., Giraud, S., Niccoli, P., Odou, M.-F., Borson-Chazot, F., Barlier, A., Lombard-Bohas, C., Clauser, E., Tabarin, A., Pasmant, E., Chabre, O., CASTERMANS, E., Ruszniewski, P., Bertherat, J., ... Goudet, P. (2015). Unravelling the intra-familial correlations and heritability of tumor types in MEN1, a GTE study. European Journal of Endocrinology, 173 (6), 819-826. doi:10.1530/EJE-15-0691 Peer Reviewed verified by ORBi |
 | Rostomyan, L.* , Daly, A.* , PETROSSIANS, P., Natchev, E., Lila, A. R., Lecoq, A.-L., Lecumberri Santamaria, B., Trivellin, G., Salvatori, R., Moraitis, A., Holdaway, I., Kranenburg-Van Klaveren, D., Zatelli, M. C., Palacios, N., Nozieres, C., Zacharin, M., Ebeling, T. M. L., Ojaniemi, M., Rozhinskaya, L., ... Beckers, A. (2015). Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocrine-Related Cancer. doi:10.1530/ERC-15-0320 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Beckers, A.* , Lodish, M.* , Trivellin, G., Rostomyan, L., Lee, M., Faucz, F., Yuan, B., Choong, C., CABERG, J.-H., Verrua, E., Naves, L. A., Cheetham, T., Young, J., Lysy, P., PETROSSIANS, P., Cotterill, A., Shah, N. S., Metzger, D., CASTERMANS, E., ... Stratakis, C.*. (2015). X-linked acrogigantism syndrome : Clinical Profile and Therapeutic responses. Endocrine-Related Cancer, 22, 353-367. doi:10.1530/ERC-15-0038 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
| VALDES SOCIN, H. G., Daly, A., Burlacu, C., CHAVEZ, V., CASTERMANS, E., DIDEBERG, V., HAMOIR, E., BISOGNI, C., BETEA, D., Bours, V., & Beckers, A. (2014). Le cancer thyroïdien papillaire familial (FNMTC): études cliniques et génétiques chez 8 familles. In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Française d'Endocrinologie, Lyon 5-8 novembre 2014. |
 | Zatelli, M. C., Tagliati, F., Di Ruvo, M., CASTERMANS, E., Cavazzini, L., Daly, A., Ambrosio, M. R., Beckers, A., & Degli Uberti, E. (2014). Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression. Familial Cancer. doi:10.1007/s10689-014-9702-y Peer Reviewed verified by ORBi |
 | Hanssen, O., CASTERMANS, E., BOVY, C., WEEKERS, L., ERPICUM, P., DUBOIS, B., Bours, V., Krzesinski, J.-M., & Jouret, F. (2014). Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. NDT Plus, 7, 282-285. doi:10.1093/ckj/sfu019 Peer Reviewed verified by ORBi |
 | Trivellin, G.* , Daly, A.* , Faucz, F. R., Yuan, B., Rostomyan, L., Larco, D. O., Schernthaner-Reiter, M. H., Szarek, E., Leal, L. F., CABERG, J.-H., CASTERMANS, E., Villa, C., Dimopoulos, A., Chittiboina, P., Xekouki, P., Shah, N. S., Metzger, D., Lysy, P. A., Ferrante, E., ... Stratakis, C. A.*. (2014). Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation. New England Journal of Medicine. doi:10.1056/NEJMoa1408028 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Rostomyan, L., Potorac, I., CASTERMANS, E., Daly, A., & Beckers, A. (2013). A giant treated with growth hormone. In The 3rd ENEA Workshop : Hypopituitarism - Abstract book (pp. 97). |
| Bothra, N., Daly, A., CASTERMANS, E., Jagtap, V., Buydal, S., Lila, A., Bandgar, T., Rostomyan, L., Potorac, I., BOURS, V., Shah, N., & Beckers, A. (October 2013). FIPA : étude clinique et génétique à l'Hôpital "King Edward Memorial", Bombay (Mumbai) Inde. Annales d'Endocrinologie, 74, 443. Peer Reviewed verified by ORBi |
 | Bruck, F.* , Belle, L.* , LECHANTEUR, C., de Leval, L., Hannon, M., DUBOIS, S., CASTERMANS, E., Humblet-Baron, S., Rahmouni, S., Beguin, Y., BRIQUET, A.* , & Baron, F.*. (March 2013). Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy, 15 (3), 267-279. doi:10.1016/j.jcyt.2012.09.003 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Thevenon, J., Bourredjem, A., Faivre, L., Cardot-Bauters, C., Calender, A., Murat, A., Giraud, S., Niccoli, P., Odou, M.-F., Borson-Chazot, F., Barlier, A., Lombard-Bohas, C., Clauser, E., Tabarin, A., Parfait, B., Chabre, O., CASTERMANS, E., BECKERS, A., Ruszniewski, P., ... Goudet, P. (2013). Higher risk of death among MEN1 patients with mutations in the JunD interacting domain. A Groupe d'étude des Tumeurs Endocrines (GTE) cohort study. Human Molecular Genetics. doi:10.1093/hmg/ddt039 Peer Reviewed verified by ORBi |
 | CASTERMANS, E., GAILLEZ, S., & BOURS, V. (2013). Existe-t-il une predisposition genetique aux addictions ? Revue Médicale de Liège, 68 (5-6), 226-32. Peer reviewed |
| Jaffrain-Rea, M.-L., ANGELINI, M., OCCHI, G., TURCHI, A., CASTERMANS, E., CECCATO, F., ARCELLA, A., ESPOSITO, V., GIANGASPERO, F., PENNELLI, G., Daly, A., ALESSE, E., SCARONI, C., & Beckers, A. (2012). Ary Hydrocarbon receptor interacting protein (AIP) on somatotroph adenomas : a molecular target for somatostatin analogues ? In Endocrine abstracts - May 2012, volume 29. |
 | Bruck, F., de Leval, L., Belle, L., LECHANTEUR, C., Hannon, M., BRIQUET, A., Dubois, S., CASTERMANS, E., Humblet-Baron, S., Rahmouni, S., BEGUIN, Y., & BARON, F. (2012). Bone marrow-derived mesenchymal stromal cells failed to prevent experimental xenogeneic graft-versus-host disease [Poster presentation]. Belgian Hematological Society General Annual Meeting. |
 | Tichomirowa, M., Lee, M., Barlier, A., Daly, A., Marinoni, I., Jaffrain-Rea, M.-L., Naves, L. A., Rodien, P., Rohmer, V., Faucz, F. R., Caron, P., Estour, B., Lecomte, P., Borson-Chazot, F., Penfornis, A., Yaneva, M., Guitelman, M., CASTERMANS, E., Verhaege, C., ... Beckers, A. (2012). Cyclin dependent kinase inhibitor (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenomas (FIPA) kindreds. Endocrine-Related Cancer, 19, 233-241. doi:10.1530/ERC-11-0362 Peer Reviewed verified by ORBi |
 | Schulte, I., Hitziger, T., Giugliano, S., Timm, J., Heinemann, F. M., Khudyakov, Y., Strasser, M., König, C., CASTERMANS, E., Mok, J. Y., van Esch, W. J., Bertoletti, A., Schumacher, T. N., & Roggendorf, M. (February 2011). Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection. Journal of Hepatology, 54 (2), 201-208. doi:10.1016/j.jhep.2010.07.010 Peer Reviewed verified by ORBi |
 | CASTERMANS, E., Hannon, M., Dutrieux, J., Humblet, S., Seidel, L., Cheynier, R., Willems, E., Gothot, A., Vanbellinghen, J.-F., Geenen, V., Sandmaier, B. M., Storb, R., Beguin, Y., & Baron, F. (2011). Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age. Haematologica, 96(2), 298-306. doi:10.3324/haematol.2010.029702 Peer Reviewed verified by ORBi |
 | Reker Hadrup, S., Bakker, A. H., Shu, C. J., Andersen, R. S., van Veluw, J., Hombrink, P., Castermans, E., Straten, P. T., Blank, C., Haanen, J. B., Heemskerk, M. H., & Schumacher, T. N. (July 2009). Parallel detection of antigen-specific T-cell responses by multidimensional encoding of peptide-Major Histocompatibility Complexes. Nature Methods, 6 ((7)), 520-526. doi:10.1038/nmeth.1345 Peer Reviewed verified by ORBi |
 | Humblet-Baron, S., CASTERMANS, E., Vanbellinghen, J.-F., Hannon, M., Jacobs, N., WILLEMS, E., Ormenese, S., Beguin, Y., & Baron, F. (February 2009). What Is The Role For Regulatory T-Cells After Nonmyeloablative Conditioning? Biology of Blood and Marrow Transplantation, 15 (2), 122-123. doi:10.1016/j.bbmt.2008.12.377 Peer Reviewed verified by ORBi |
 | Castermans, E., Hannon, M., Drion, P., Geenen, V., Beguin, Y., & Baron, F. (2009). Reconstitution du système immunitaire après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (S1), 2-8. Peer reviewed |
Castermans, E. (2008). Contribution à l'étude de la reconstitution immunitaire après miniallogreffe de cellules souches hématopoïétiques [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315296 |
 | Humblet-Baron, S., CASTERMANS, E., Vanbellighen, J.-F., Hannon, M., Jacobs, N., Beguin, Y., & Baron, F. (February 2008). What is the Role for Regulatory T-Cells after Nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 14 (2), 136-137. doi:10.1016/j.bbmt.2007.12.383 Peer Reviewed verified by ORBi |
 | Castermans, E.* , Baron, F.* , Willems, E., Schaaf-Lafontaine, N., Meuris, N., Gothot, A., Vanbellinghen, J.-F., Herens, C., Seidel, L., Geenen, V., Cheynier, R., & Beguin, Y. (2008). Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica, 93 (2), 240-7. doi:10.3324/haematol.11708 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Geenen, V., Beguin, Y., & Baron, F. (2007). Evaluation de la thymopoiese: applications cliniques. Revue Médicale de Liège, 62 (12), 725-9. Peer reviewed |
 | Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Baron, F., Beguin, Y., & Geenen, V. (2007). Evaluation clinique de la fonction du thymus. Revue Médicale de Liège, 62 (11), 675-8. Peer reviewed |
 | Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (May 2006). Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Molecular Pharmacology, 69 (5), 1615-1623. doi:10.1124/mol.105.020479 Peer Reviewed verified by ORBi |
 | WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2006). Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial [Paper presentation]. 21st General Meeting of the Belgian Hematological Society. |
 | Pirson, L.* , Baron, F.* , Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2006). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice. Stem Cells, 24 (7), 1814-21. doi:10.1634/stemcells.2005-0290 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Castermans, E., Baron, F., Willems, E., Meuris, N., Schaaf-Lafontaine, N., Reynier, R., Geenen, V., & Beguin, Y. (2006). Immune reconstitution after CD8-depleted or unmanipulated peripheral blood stem cells transplantation with nonmyeloablative conditioning. Acta Clinica Belgica, 61 (2), 113. Peer Reviewed verified by ORBi |
Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (September 2005). SERMs-induced myeloma cell apoptosis: A study of NF-kappa B inhibition and gene expression signature. Journal of Bone and Mineral Research, 20 (9, Suppl. 1), 213. |
Pirson, L., Baron, F., Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2005). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDBeta2mNull [Poster presentation]. 20th general meeting of the Belgian Hematological Society, Brussels, Belgium. |
 | WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075). Peer Reviewed verified by ORBi |
 | Geenen, V., Poulin, J. F., Dion, M. L., Martens, H., Castermans, E., Hansenne, I., Moutschen, M., Sekaly, R. P., & Cheynier, R. (2003). Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. Journal of Endocrinology, 176 (3), 305-311. doi:10.1677/joe.0.1760305 Peer Reviewed verified by ORBi |
 | Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7 Peer Reviewed verified by ORBi |